Sentinus LLC’s Sensus Healthcare SRTS Stock Holding History

Sentinus LLC’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-125,586	Closed	-$500K	–	656
2025 Q4	$500K	Buy	+125,586	New	+$465K	0.05%	302

Other funds holding SRTS

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

GWM

Greenline Wealth Management Boca Raton, Florida $86.7M AUM

Sentinus LLC's SRTS Position: Q1 2026 in Review

Sentinus LLC sold out of Sensus Healthcare (SRTS) in Q1 2026, closing a stake of 125,586 shares — an estimated $500K sold.

Sentinus LLC first reported a position in SRTS in Q4 2025 and held it in 1 quarter. The position peaked at $500K in Q4 2025. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

Sentinus LLC reported no remaining Sensus Healthcare position as of Q1 2026 after selling out during the quarter.
Sentinus LLC sold 125,586 Sensus Healthcare shares in Q1 2026, an estimated $500K.
Sentinus LLC first reported a position in Sensus Healthcare in Q4 2025 and held it in 1 quarter.
Sentinus LLC's Sensus Healthcare position peaked at $500K in Q4 2025.
41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.